NCT02946320

Brief Summary

The purpose of this study is to determine the optimal way of predilatation for BVS implantation.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Nov 2016

Shorter than P25 for phase_3

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 21, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 27, 2016

Completed
5 days until next milestone

Study Start

First participant enrolled

November 1, 2016

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
Last Updated

October 27, 2016

Status Verified

October 1, 2016

Enrollment Period

4 months

First QC Date

October 21, 2016

Last Update Submit

October 25, 2016

Conditions

Keywords

PCI, bioabsorbable scaffold

Outcome Measures

Primary Outcomes (1)

  • Minimal lumen area (MLA) in the BVS (mm2)

    After BVS implantation, optical coherence tomography is used to measure MLA in the scaffold area.

    Immediately after BVS implantation

Secondary Outcomes (3)

  • Clinically - driven target vessel revascularization

    12 months after the procedure

  • Eccentricity index

    Immediately after BVS implantation

  • Expansion index

    Immediately after BVS implantation

Study Arms (3)

Non-compliant balloon

ACTIVE COMPARATOR

15 patients, before BVS implantation is coronary artery stenosis dilated with this type of balloon

Device: Predilatation with non-compliant balloon

Scoring balloon

EXPERIMENTAL

15 patients, before BVS implantation is coronary artery stenosis dilated with this type of balloon

Device: Predilatation with scoring balloon (Scoroflex)

Cutting balloon

EXPERIMENTAL

15 patients, before BVS implantation is coronary artery stenosis dilated with this type of balloon

Device: Predilatation with cutting balloon (Flextome)

Interventions

Coronary artery stenosis is dilated before BVS implantation with the use of non-compliant balloon (standard procedure). Size and dilatation pressure is done according to OCT measurement of the coronary artery (distal segment / balloon diameter = 1:1)

Non-compliant balloon

Coronary artery stenosis is dilated before BVS implantation with the use of scoring balloon. Size and dilatation pressure is done according to OCT measurement of the coronary artery (distal segment / balloon diameter = 1:1)

Scoring balloon

Coronary artery stenosis is dilated before BVS implantation with the use of cutting balloon. Size and dilatation pressure is done according to OCT measurement of the coronary artery (distal segment / balloon diameter = 1:1)

Cutting balloon

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients undergoing percutaneous coronary intervention (PCI)
  • lesion no more than 25 mm in length with a reference-vessel diameter of 2.5 to 3.75 mm on visual assessment

You may not qualify if:

  • patients with acurate myocardial infarction (STEMI)
  • patients with specific complex lesion features (left main, aorto ostial, bifurcation with side branch ≥ 2 mm in diameter, extreme angulation proximal or within the target lesion, moderate or heavy calcification proximal or within the target lesion, chronic total occlusion)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Coronary Stenosis

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular Diseases

Study Officials

  • Ivo Varvařovský, MUDr, Ph.D

    Cardiology Center AGEL a.s.

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Petra Jiroušková, Mgr

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Cardiology Center Agel

Study Record Dates

First Submitted

October 21, 2016

First Posted

October 27, 2016

Study Start

November 1, 2016

Primary Completion

March 1, 2017

Study Completion

March 1, 2017

Last Updated

October 27, 2016

Record last verified: 2016-10

Data Sharing

IPD Sharing
Will share